Your English writing platform
Discover LudwigExact(14)
These results introduce a novel finding that miR-223 is involved in the ossification defect in MT-COMP mice making it a therapeutic target.
The immune response, however, can be different between individual mice making it possible to select the mouse that produces antibodies with favorable properties.
Further, SFTI-FCQR Asn14 was stable in a cancer cell milieu and bioavailable by intraperitoneal perfusion in mice, making it an attractive candidate for further therapeutic development.
However, due to immune tolerance, some proteins that are highly conserved between mice and humans are not very immunogenic in mice, making it difficult to generate antibodies using a conventional approach.
Efficacious concentrations of this compound are also well tolerated by mice, making it an attractive prospect for clinical use [ 97].
Moreover, AV-65 treatment prolongs the survival of MM-bearing mice, making it an attractive agent against MM.
Similar(45)
Yet, the similarity of human immune response in the absence of GFP to the response in its presence in mice makes it least likely.
Three brave and resourceful mice make it to the finals; naturellement, Sophie is among them.
However, if the black mouse tastes different than a white mouse, then the hawk will continue to eat white mice even after black mice make it sick (Brett et al. 1976).
However, the early and progressive evolution of the muscle phenotype, the fragility and the high degree of lethality of these mutant mice made it difficult to investigate the function of SRF in fully mature muscle physiology.
On the other hand, the much greater severity of the phenotype of the Tgfb1−/−mice than the Thbs1−/− mice makes it clear that a mechanism(s) of TGF-β1 activation that does not require TSP-1 must exist in vivo.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com